October21 , 2026

    Pharma.Aero Welcomes JAL Cargo to Boost Global Pharma Logistics Network

    Related

    MoPSW Secretary Reviews Operational Facilities and Development Projects at VOC Port

    V.O. Chidambaranar (VOC) Port Authority is stepping up efforts...

    DP World Seeks Permanent NSICT Terminal Rights Through JV Proposal

    DP World has proposed forming a joint venture (JV)...

    Keralam Plans Vizhinjam Cruise Tourism Hub to Attract International Visitors

    Keralam is planning to develop Vizhinjam as an international...

    SMP Kolkata Handles 34.75 MT of Cargo in H1FY27, Records 4% Growth

    Syama Prasad Mookerjee Port (SMP), Kolkata, handled 34.75 million...

    TCCI Seeks Time-Bound Probe into Alleged Lapses in Vizhinjam Port Expansion

    The Trivandrum Chamber of Commerce and Industry (TCCI) has...

    Share

    Pharma.Aero has welcomed JAL Cargo as its newest member, a move expected to strengthen the global network dedicated to advancing pharmaceutical air logistics and supply chain standards. The addition of the Japanese carrier expands collaboration across key healthcare trade lanes in Asia and beyond.

    JAL Cargo’s entry into the organization is set to enhance expertise in temperature-controlled transport, cargo quality assurance and time-sensitive healthcare shipments. As demand for biopharmaceuticals, vaccines and specialty medicines grows, reliable air cargo capacity remains critical to global distribution.

    Pharma.Aero brings together airlines, airports, shippers and logistics stakeholders to improve end-to-end pharma supply chains through innovation, compliance and data-driven best practices. The inclusion of JAL Cargo adds strategic reach in one of the world’s important life sciences and export markets.

    Industry participants say stronger cooperation between carriers and logistics partners is increasingly essential as pharmaceutical supply chains become more complex and quality requirements more stringent.

    The partnership underscores continued momentum in building resilient, efficient and globally connected pharma logistics networks.